Unlocking the Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss and Heart Health
Episode Summary
Emerging obesity treatments may deliver both weight-loss and cardiovascular benefits, offering new options to reduce heart disease risk while addressing the growing obesity epidemic.